Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3687135 A
Publication typeGrant
Publication dateAug 29, 1972
Filing dateSep 15, 1969
Priority dateAug 20, 1969
Also published asDE1953241A1, DE1953241B2
Publication numberUS 3687135 A, US 3687135A, US-A-3687135, US3687135 A, US3687135A
InventorsVladislav Sergeevich Borodkin, Evgeny Mikhailovich Savitsky, Konstantin Mitrofanovic Sivash, Genrikh Borisovich Stroganov, Vera Fedorovna Terekhova, Nina Mikhailovna Tikhova, Mstislav Vasilievich Volkov
Original AssigneeEvgeny Mikhailovich Savitsky, Genrikh Borisovich Stroganov, Konstantin Mitrofanovich Sivas, Mstislav Vasilievich Volkov, Nina Mikhailovna Tikhova, Vera Fedorovna Terekhova, Vladislav Sergeevich Borodkin
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Magnesium-base alloy for use in bone surgery
US 3687135 A
Abstract
A magnesium-base alloy for use in bone surgery which contains the following components, wt.%:
Images(4)
Previous page
Next page
Description  (OCR text may contain errors)

waited States Patent Stroganov et a1.

[54] MAGNESIUM-BASE ALLOY FOR USE IN BONE SURGERY [72] Inventors: Genrikh Borisovich Stroganov, 2

Voikovsky proezd, 1, kv. 29; Evgeny Mikhailovich Savitsky, ulitsa Dmitria Ulyanova, 3, kv. 13; Nina Mikhailovna Tikhova, Frunzenskaya naberezhnaya, 38/1, kv. 394; Vera Fedorovna Terekhova, Belyaevo- Bogorodskoe, kvartal 48, korpus 23, kv. 235; Mstislav Vasilievich Volkov, 1 Stroitelnaya ulitsa, 6, korpus 5, kv. 10; Konstantin Mitrofanovich Sivash, B. Pirogovskaya ulitsa,

37/43 A, kv. 49; Vladislav Sergeevich Borodkin, Shelepikha, 5 ulitsa, 6/8, kv. 91, all of, Moscow, USSR.

[22] Filed: Sept. 15, 1969 [21] Appl. No.: 858,149

[52] US. Cl. ..128/92 B, 75/168 R, 75/168 M, 75/168 .1, 128/92 BA, 128/92 BB, 128/92 BC, 128/92 C [51] Int. Cl. ..C22c 23/00, A61f 5/01 [58] Field of Search..75/l68; 128/92 R, 92 B, 92 BB, 128/92 BA, 92 BC, 92 C, 92 CA, 92 D; 3/1

[ 51 Aug. 29, 1972 2,221,319 11/1940 Altwicker et a] ..75/168 B 2,549,955 4/1951 Jessup et a]. ..75/168 J OTHER PUBLICATIONS Annals of Surgery, Vol. 105, No. 6, June 1937, pp. 919, 920 & 938.

Primary ExaminerCharles N. Lovell Att0rneyWaters, Roditi, Schwartz & Nissen [57] ABSTRACT A magnesium-base alloy for use in bone surgery which contains the following components, wt.%:

Rare earth element 0.4-4.0 Cadmium 005-1 .2 An element from the group consisting of calcium and aluminum 0.05-1 .0 Manganese 0.05-.05 Silver 0-0.8 Zirconium 0-0.8 Silicon 0-0.3 Magnesium remainder 5 Claims, N0 Drawings MAGNES-BASE ALLOY FOR USE IN BONE SURGERY The present invention relates to magnesium-base alloys employed as a joining and fixation material in bone surgery.

One of the main problems in the operative treatment of bone fractures is finding a material for fixation means which is sufficiently strong, is absorbed after the completion of union and stimulates callus formation. The search for such a material has been made predominantly among organic substances although there are isolated reports of the study and use of inorganic materials, particularly metals.

Magnesium was first employed for osteosynthesis by Lambotte in 1907. In fracture of the bones of the lower leg a magnesium plate secured with gold-plate steel nails was used, but in 8 days the plate disintegrated with the formation of a large amount of gas under the skin. In spite of Lambottes failure, study of the effect of magnesium on the surrounding tissue and the body as a whole continued.

An attempt to use pure magnesium for osteosynthesis was unsuccessful because magnesium pins disintegrated so quickly that they were unsuitable for the fixation of bone fragments; nevertheless, clinical, X-ray and histological investigations demonstrated that pure magnesium introduced into the body in the form of a pin has no harmful effect.

Attempts were made to dust bone transplants with magnesium and calcium in vacuum and then graft them in the patients body. It was found that magnesium and calcium promoted rapid restoration of the entirety of the bone, this taking place 3 months sooner than when an untreated autotransplant was employed. Said method, however, is laborious and requires drainage for drawing off the gas formed.

Magnesium alloys with other metals have also been tried. Verbrugge used an alloy consisting of 92 percent magnesium and 8 percent aluminum; E. Bride reported the use of an alloy consisting of 95 percent magnesium, 4.7 percent aluminum and 0.3 percent manganese; M.S. Znamensky used an alloy consisting of 97.3 percent magnesium, 2.5 percent aluminum and 0.2 percent beryllium; B.I. Klepatsky tried an alloy consisting of 82.8 percent magnesium, 85 percent aluminum, 8.5 percent zinc and 0.2 percent manganese.

A review of the literature indicates that magnesium alloys employed for making fixation means dissolve completely in the bone and have no detrimental effect either locally or generally. However, the absorption of previously known magnesium alloys proceeds three or four times more rapidly than required from the standpoint of restoration of the entirety of the bone. Moreover, when said known alloys are used, drainage is necessary to remove the gas formed.

It is an object of the present invention to provide a magnesium-base alloy which has a rate of absorption slower than the process of bone consolidation, which does not involve vigorous evolution of gas and which has high mechanical strength.

It is another object of the invention to provide a magnesium-base alloy which meets the following requirements:

1. Ultimate strength a 28 kg/mm and yield point 2 18 kg/mm, i.e., the alloys mechanical strength shall exceed that of bone tissue;

2. The rate of absorption of the alloy compared to the rate of consolidation of the bone shall be such that at the moment of complete restoration of the bones entirety the alloy shall retain sufficient strength, i.e., the process of absorption shall be completed 1.5-2 months after knitting of the bone;

3. The rate of evolution of hydrogen during absorption of the alloy in the body shall be less or equal to the rate of absorption of hydrogen by the body.

4. The alloy shall contain elements which stimulate the growth of bone tissue, such as calcium and cadmium;

5. The alloy shall not contain elements which are harmful for the living organism, such as lead, beryllium, copper, thorium, zinc, nickel, etc.

The foregoing objects have been accomplished by the provision of a magnesium-base alloy which, accord ing to the invention, contains the following elements,

Rare earth metal 0.40-4.0 Cadmium 005-1 .2 Calcium or aluminum 0.05-1 .0 Manganese 0.05-1.0 Silver 00.8 Zirconium 0-O.8 Silicon 00.3 Magnesium remainder Neodymium and yttrium are predominantly employed as the rare earth metal although other rare earth metals can be used.

The above alloy is produced by the conventional method by preparing a charge consisting of pure metals and master alloys and melting the same.

One of the advantages of the invention is that it provides an alloy having high chemico-physiological, mechanical and engineering properties. The ultimate strength of said alloy e 28 kg/mm and the yield point a 18 kglmm Employment of said alloy for joining bone fragments obviates the necessity of a second operation on the patient for the removal of foreign fastening means (pins, nails, etc.) since said alloy is completely absorbed without the accumulation of gas. Moreover, the stimulation of callus formation promotes the pateients rapid recovery.

The following examples of variations in the composition of the alloy according to the invention are given by way of illustration.

EXAMPLE 1 Illustrates an alloy of the following composition, wt.%:

Neodymium 2.92 Cadmium 0.27 Calcium 0.24 Manganese 0.1 1 Magnesium remainder The above alloy has the following properties:

Ultimate strength 32.6 kg/mm Yield point 24.5 kg/mm Elongation 6.3%

Said alloy was tested in a physiological solution containing 0.9 wt.% NaCl, 0.02 wt.% KCl, 0.02 wt.% CaCl 0.002 wt.% Na CO and the remainder, distilled water. Evolution of hydrogen in 48 hours totalled 3.4 cm /cm The result of the test indirectly gives a conception of the process of absorption of the metal in the body.

EXAMPLE 2 Illustrates an alloy of the following composition, wt.%:

Neodymium 2.46 Cadmium 0. l 2 Aluminum 0.09 Manganese 0. l 4 Silicon 0.01 Magnesium remainder The above alloy has the following properties:

Ultimate strength 31.6 lrg/mm Yield point 25.3 ltg/mm" Elongation 3.7% Hydrogen evolution in physiological solution of Example I, 48 hrs. 2.1 em /cm EXAMPLE 3 Illustrates an alloy of the following composition, wt.%

Yttrium 1.6 Cadmium 0.25 Calcium 0.06

Silver 0.3 Manganese 0.08 Magnesium remainder The above alloy has the following properties:

Ultimate strength 28.4 kg/nim Yield point 23.6 kg/mm Elongation 5.5% Hydrogen evolution in physiological solution of Example 1, 48 hrs. [.6 cmVcrn EXAMPLE 4 Illustrates an alloy of the following composition, wt.%:

Neodymium Cadmium Calcium 0.08 Manganese 0.13 Zirconium 0.49 Magnesium remainder The above alloy has the following properties:

Ultimate strength 32.2 kglmm Yield point 21.8 kg/mrn Elongation 8.9% Hydrogen evolution in physiological solution of Example I, 48 hrs. 2.0 cm lcm MgCl, 34-40 KC] 25-36 NaCl CaCl s 8.0

CaF, -20

MgO 7-10 After melting and thoroughly mixing, the alloy was refined with the above flux and let stand for 15-20 minutes, after which it was poured at a temperature of 760-780C through a magnesite filter into moulds.

After preheating and hot pressing at 520-540C the blanks were cooled in the air after which they were artificially aged at 16021 0C for 16 hours.

The alloys thus produced were ready for use. Employment of the alloys specified in Examples 1, 2, 3 and 4 for joining bones in bone surgery demonstrated that all of said alloys possessed high mechanical and chemico-physiological properties. Clinical tests showed that said alloys were completely absorbed: pins 3 mm in diameter in 5 months and pins 8 mm in diameter in l 1 months. Bones knitted in 4 months.

F luoroscopic examination revealed no gas bubbles in the soft tissues during the entire period of absorption of said alloys.

Operative treatment of fractures by means of the I present alloy reduces the time required for union of the bone by 33-50 percent. In this respect the best showing was made by the alloy described in Example 2.

As is apparent from the figures cited, evolution of gas by the alloys described in Examples 1, 2, 3 and 4 is within the bodys absorptive capacity, since said capacity is 4.0-4.5 cm of gas from each sq.cm. of surface of the metal being absorbed per 48 hrs.

We claim:

1. A bone fastening device, for the fixation of bone fragments, constructed of an alloy, consisting essen tially of, by wt.%:

Rare earth element 0.4-4.0 Cadmium 0.05-2.22 An element selected from the group consisting of calcium and aluminum (-1 .0 Manganese ODS-0.5 Silver 00.8 Zirconium 0-0.8 Silicon O-0.3 Magnesium remainder 2. A device as in claim I which has the following composition by wt.%:

Neodymium 2.92 Cadmium 0.27 Calcium 0.24 Manganese 0.! 1 Magnesium remainder 3. A device as in claim 1 which has the following composition, by wt.%:

Neodymium 2.46 Cadmium 0. l 2 Aluminum 0.09 Manganese 0.14 Silicon 0.01 Magnesium remainder 4. A device as in claim 1 which has the following compositions, wt.%:

Yttrium L6 Cadmium 0.25 Calcium 0.06 Silver 0.3 Manganese 0.08 Magnesium remainder composition, wt.%:

Neodymium Cadmium Calcium Manganese Zirconium Magnesium remainder

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2094578 *Sep 1, 1933Oct 5, 1937Bernhard BlumenthalMaterial for surgical ligatures and sutures
US2221319 *Oct 22, 1938Nov 12, 1940Magnesium Dev CorpMagnesium base alloy
US2270194 *Dec 23, 1940Jan 13, 1942Dow Chemical CoMagnesium base alloy
US2286866 *Dec 23, 1940Jun 16, 1942Dow Chemical CoMagnesium base alloy
US2549955 *Jan 4, 1949Apr 24, 1951Magnesium Elektron LtdMagnesium base alloys
Non-Patent Citations
Reference
1 *Annals of Surgery, Vol. 105, No. 6, June 1937, pp. 919, 920 & 938.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US4269721 *Dec 21, 1979May 26, 1981Stauffer Chemical CompanyDust abatement with calcium sulfate
US6767506 *Mar 14, 2002Jul 27, 2004Dead Sea Magnesium Ltd.High temperature resistant magnesium alloys
US7048812 *Jun 20, 2003May 23, 2006Cast Centre Pty Ltdalloy of magnesium, neobymium, zinc, zirconium, manganese and rare earth elements; creep resistant at high temperatures, engine blocks
US7077860Jun 24, 2004Jul 18, 2006Advanced Cardiovascular Systems, Inc.Medical insert coated with compound that bonds to heparin
US7198675Sep 30, 2003Apr 3, 2007Advanced Cardiovascular SystemsStent mandrel fixture and method for selectively coating surfaces of a stent
US7229471Sep 10, 2004Jun 12, 2007Advanced Cardiovascular Systems, Inc.Compositions containing fast-leaching plasticizers for improved performance of medical devices
US7258891Apr 7, 2003Aug 21, 2007Advanced Cardiovascular Systems, Inc.Reduct coating, controlling thickness in support contactor zones
US7285304Jun 25, 2003Oct 23, 2007Advanced Cardiovascular Systems, Inc.Coating the device with a polymer, an active agent and a solvent; evaporating the solvent; and applying a polymer-free fluid to the dry coating to increase the crystallinity of the polymer
US7291166May 18, 2005Nov 6, 2007Advanced Cardiovascular Systems, Inc.Polymeric stent patterns
US7297159Jul 21, 2004Nov 20, 2007Advanced Cardiovascular Systems, Inc.Selective coating of medical devices
US7297758Aug 2, 2005Nov 20, 2007Advanced Cardiovascular Systems, Inc.Method for extending shelf-life of constructs of semi-crystallizable polymers
US7329366Jun 18, 2004Feb 12, 2008Advanced Cardiovascular Systems Inc.Method of polishing implantable medical devices to lower thrombogenecity and increase mechanical stability
US7381048Apr 12, 2005Jun 3, 2008Advanced Cardiovascular Systems, Inc.Stents with profiles for gripping a balloon catheter and molds for fabricating stents
US7476245Aug 16, 2005Jan 13, 2009Advanced Cardiovascular Systems, Inc.Polymeric stent patterns
US7553377Apr 27, 2004Jun 30, 2009Advanced Cardiovascular Systems, Inc.Apparatus and method for electrostatic coating of an abluminal stent surface
US7563324Dec 29, 2003Jul 21, 2009Advanced Cardiovascular Systems Inc.System and method for coating an implantable medical device
US7604700Jan 16, 2007Oct 20, 2009Advanced Cardiovascular Systems, Inc.Stent mandrel fixture and method for selectively coating surfaces of a stent
US7622070Jun 20, 2005Nov 24, 2009Advanced Cardiovascular Systems, Inc.Tubing-mandrels; stents
US7632307Dec 16, 2004Dec 15, 2009Advanced Cardiovascular Systems, Inc.Abluminal, multilayer coating constructs for drug-delivery stents
US7658880Jul 29, 2005Feb 9, 2010Advanced Cardiovascular Systems, Inc.Polymeric stent polishing method and apparatus
US7662326Apr 27, 2007Feb 16, 2010Advanced Cardiovascular Systems, Inc.Compositions containing fast-leaching plasticizers for improved performance of medical devices
US7699890Jan 28, 2004Apr 20, 2010Advanced Cardiovascular Systems, Inc.Medicated porous metal prosthesis and a method of making the same
US7708548Apr 10, 2008May 4, 2010Advanced Cardiovascular Systems, Inc.Molds for fabricating stents with profiles for gripping a balloon catheter
US7731890Jun 15, 2006Jun 8, 2010Advanced Cardiovascular Systems, Inc.conveying a gas into a poly(L-lactide) tube disposed within a cylindrical mold to increase pressure inside tube, wherein increased pressure radially expands tube to conform to inside surface of the mold, applying tension along axis of the tube to axially extend tube, fabricating stent from expanded tube
US7740791Jun 30, 2006Jun 22, 2010Advanced Cardiovascular Systems, Inc.Method of fabricating a stent with features by blow molding
US7757543Jul 13, 2006Jul 20, 2010Advanced Cardiovascular Systems, Inc.Radio frequency identification monitoring of stents
US7758881Mar 24, 2005Jul 20, 2010Advanced Cardiovascular Systems, Inc.stents having everolimus and clobetasol; restenosis, vulnerable plaque; biodegradable
US7761968May 25, 2006Jul 27, 2010Advanced Cardiovascular Systems, Inc.Method of crimping a polymeric stent
US7794495Jul 17, 2006Sep 14, 2010Advanced Cardiovascular Systems, Inc.A stent having a structural element made of a polymer with a hydrolytically degradable L-lactide block and a polystyrenesulfonate or poly(2-acrylamido-2-methylpropanesulfonic acid) block in which the acid group is protecting group; when deprotected the acid group initiates degradation
US7794776Jun 29, 2006Sep 14, 2010Abbott Cardiovascular Systems Inc.modifying molecular weight, comprises polyester amide coating; improving degradation rate and drug release rate
US7823263Jul 9, 2007Nov 2, 2010Abbott Cardiovascular Systems Inc.Method of removing stent islands from a stent
US7829008May 30, 2007Nov 9, 2010Abbott Cardiovascular Systems Inc.Fabricating a stent from a blow molded tube
US7842737Sep 29, 2006Nov 30, 2010Abbott Cardiovascular Systems Inc.Polymer blend-bioceramic composite implantable medical devices
US7867547Dec 19, 2005Jan 11, 2011Advanced Cardiovascular Systems, Inc.spray coating with anti-coagulant, platelet inhibitor and/or pro-healing substance; cured via electrical resistance heater
US7875233Jul 18, 2005Jan 25, 2011Advanced Cardiovascular Systems, Inc.Method of fabricating a biaxially oriented implantable medical device
US7879367 *Jul 17, 1998Feb 1, 2011Alfons FischerStent is magnesium and/or iron alloy; biodegradable, eliminates need for permanent implants within blood vessels; mechanical properties
US7886419Jul 18, 2006Feb 15, 2011Advanced Cardiovascular Systems, Inc.Stent crimping apparatus and method
US7901452Jun 27, 2007Mar 8, 2011Abbott Cardiovascular Systems Inc.Method to fabricate a stent having selected morphology to reduce restenosis
US7905902Jun 16, 2003Mar 15, 2011Ethicon Endo-Surgery, Inc.Surgical implant with preferential corrosion zone
US7923022Sep 13, 2006Apr 12, 2011Advanced Cardiovascular Systems, Inc.stent body is made of polylactone copolymer consisting of monomers selected from lactic acid, glycolic acid and hydroxyhexanoic acid; copolymerized in solvent; mechanical stability, nonbrittleness, fracturing resist
US7951185Jan 6, 2006May 31, 2011Advanced Cardiovascular Systems, Inc.Delivery of a stent at an elevated temperature
US7951194May 22, 2007May 31, 2011Abbott Cardiovascular Sysetms Inc.Bioabsorbable stent with radiopaque coating
US7955381Jun 29, 2007Jun 7, 2011Advanced Cardiovascular Systems, Inc.Polymer-bioceramic composite implantable medical device with different types of bioceramic particles
US7955382Sep 14, 2007Jun 7, 2011Boston Scientific Scimed, Inc.Endoprosthesis with adjustable surface features
US7959857Jun 1, 2007Jun 14, 2011Abbott Cardiovascular Systems Inc.Radiation sterilization of medical devices
US7959940May 30, 2006Jun 14, 2011Advanced Cardiovascular Systems, Inc.Polymer-bioceramic composite implantable medical devices
US7964210Mar 31, 2006Jun 21, 2011Abbott Cardiovascular Systems Inc.Degradable polymeric implantable medical devices with a continuous phase and discrete phase
US7967998Jan 3, 2008Jun 28, 2011Advanced Cardiocasvular Systems, Inc.Method of polishing implantable medical devices to lower thrombogenecity and increase mechanical stability
US7971333May 30, 2006Jul 5, 2011Advanced Cardiovascular Systems, Inc.Manufacturing process for polymetric stents
US7985252Jul 30, 2008Jul 26, 2011Boston Scientific Scimed, Inc.Bioerodible endoprosthesis
US7989018Mar 31, 2006Aug 2, 2011Advanced Cardiovascular Systems, Inc.Fluid treatment of a polymeric coating on an implantable medical device
US7998192May 9, 2008Aug 16, 2011Boston Scientific Scimed, Inc.Endoprostheses
US7998404Jul 13, 2006Aug 16, 2011Advanced Cardiovascular Systems, Inc.Reduced temperature sterilization of stents
US8002821Sep 13, 2007Aug 23, 2011Boston Scientific Scimed, Inc.Bioerodible metallic ENDOPROSTHESES
US8003156May 4, 2006Aug 23, 2011Advanced Cardiovascular Systems, Inc.Rotatable support elements for stents
US8007529Aug 1, 2008Aug 30, 2011Advanced Cardiovascular Systems, Inc.Medicated porous metal prosthesis
US8016879Jun 27, 2007Sep 13, 2011Abbott Cardiovascular Systems Inc.Drug delivery after biodegradation of the stent scaffolding
US8017237Jun 23, 2006Sep 13, 2011Abbott Cardiovascular Systems, Inc.Nanoshells on polymers
US8034287May 15, 2007Oct 11, 2011Abbott Cardiovascular Systems Inc.Radiation sterilization of medical devices
US8043553Sep 30, 2004Oct 25, 2011Advanced Cardiovascular Systems, Inc.Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article
US8048150Apr 12, 2006Nov 1, 2011Boston Scientific Scimed, Inc.Endoprosthesis having a fiber meshwork disposed thereon
US8048441Jun 25, 2007Nov 1, 2011Abbott Cardiovascular Systems, Inc.Nanobead releasing medical devices
US8048448Jun 15, 2006Nov 1, 2011Abbott Cardiovascular Systems Inc.Nanoshells for drug delivery
US8052743Aug 2, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Endoprosthesis with three-dimensional disintegration control
US8052744Sep 13, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Medical devices and methods of making the same
US8052745Sep 13, 2007Nov 8, 2011Boston Scientific Scimed, Inc.Endoprosthesis
US8057534Sep 14, 2007Nov 15, 2011Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8080055Dec 27, 2007Dec 20, 2011Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8089029Feb 1, 2006Jan 3, 2012Boston Scientific Scimed, Inc.Bioabsorbable metal medical device and method of manufacture
US8099849Dec 13, 2006Jan 24, 2012Abbott Cardiovascular Systems Inc.Optimizing fracture toughness of polymeric stent
US8118857Nov 29, 2007Feb 21, 2012Boston Scientific CorporationMedical articles that stimulate endothelial cell migration
US8128688Jun 19, 2007Mar 6, 2012Abbott Cardiovascular Systems Inc.Carbon coating on an implantable device
US8128689Sep 14, 2007Mar 6, 2012Boston Scientific Scimed, Inc.Bioerodible endoprosthesis with biostable inorganic layers
US8172897Jun 28, 2004May 8, 2012Advanced Cardiovascular Systems, Inc.Polymer and metal composite implantable medical devices
US8172908Dec 23, 2008May 8, 2012The University Of Hong KongImplant for tissue engineering
US8173062Sep 30, 2004May 8, 2012Advanced Cardiovascular Systems, Inc.Controlled deformation of a polymer tube in fabricating a medical article
US8197879Jan 16, 2007Jun 12, 2012Advanced Cardiovascular Systems, Inc.Method for selectively coating surfaces of a stent
US8202528Jun 5, 2007Jun 19, 2012Abbott Cardiovascular Systems Inc.Implantable medical devices with elastomeric block copolymer coatings
US8236046Jun 10, 2008Aug 7, 2012Boston Scientific Scimed, Inc.Bioerodible endoprosthesis
US8241554Jun 29, 2004Aug 14, 2012Advanced Cardiovascular Systems, Inc.Method of forming a stent pattern on a tube
US8262723Apr 9, 2007Sep 11, 2012Abbott Cardiovascular Systems Inc.Implantable medical devices fabricated from polymer blends with star-block copolymers
US8267992Mar 2, 2010Sep 18, 2012Boston Scientific Scimed, Inc.Self-buffering medical implants
US8293260Jun 5, 2007Oct 23, 2012Abbott Cardiovascular Systems Inc.Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices
US8293367Jul 15, 2011Oct 23, 2012Advanced Cardiovascular Systems, Inc.Nanoshells on polymers
US8303643May 21, 2010Nov 6, 2012Remon Medical Technologies Ltd.Method and device for electrochemical formation of therapeutic species in vivo
US8333000Jun 19, 2006Dec 18, 2012Advanced Cardiovascular Systems, Inc.Methods for improving stent retention on a balloon catheter
US8343530Dec 22, 2006Jan 1, 2013Abbott Cardiovascular Systems Inc.Polymer-and polymer blend-bioceramic composite implantable medical devices
US8382824Oct 3, 2008Feb 26, 2013Boston Scientific Scimed, Inc.Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides
US8398680Apr 7, 2010Mar 19, 2013Lsi Solutions, Inc.Bioabsorbable magnesium knots for securing surgical suture
US8425591Jun 11, 2007Apr 23, 2013Abbott Cardiovascular Systems Inc.Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
US8425835Nov 11, 2003Apr 23, 2013Biotronik Vi Patent AgEndoprosthesis
US8435281Apr 10, 2009May 7, 2013Boston Scientific Scimed, Inc.Bioerodible, implantable medical devices incorporating supersaturated magnesium alloys
US8435550Aug 13, 2008May 7, 2013Abbot Cardiovascular Systems Inc.Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US8465789Jul 18, 2011Jun 18, 2013Advanced Cardiovascular Systems, Inc.Rotatable support elements for stents
US8470014Aug 14, 2007Jun 25, 2013Advanced Cardiovascular Systems, Inc.Stent-catheter assembly with a releasable connection for stent retention
US8486135Apr 9, 2007Jul 16, 2013Abbott Cardiovascular Systems Inc.Implantable medical devices fabricated from branched polymers
US8535372Jun 18, 2007Sep 17, 2013Abbott Cardiovascular Systems Inc.Bioabsorbable stent with prohealing layer
US8568469Jun 28, 2004Oct 29, 2013Advanced Cardiovascular Systems, Inc.Stent locking element and a method of securing a stent on a delivery system
US8592036Sep 20, 2012Nov 26, 2013Abbott Cardiovascular Systems Inc.Nanoshells on polymers
US8596215Jul 18, 2011Dec 3, 2013Advanced Cardiovascular Systems, Inc.Rotatable support elements for stents
US8603530Jun 14, 2006Dec 10, 2013Abbott Cardiovascular Systems Inc.Nanoshell therapy
US8637110Jul 18, 2011Jan 28, 2014Advanced Cardiovascular Systems, Inc.Rotatable support elements for stents
US8663401Nov 21, 2011Mar 4, 2014Schlumberger Technology CorporationDegradable compositions, apparatus comprising same, and methods of use
US8668732Mar 22, 2011Mar 11, 2014Boston Scientific Scimed, Inc.Surface treated bioerodible metal endoprostheses
US8715339Nov 21, 2011May 6, 2014Boston Scientific Scimed, Inc.Bioerodible endoprostheses and methods of making the same
US8741379Jul 18, 2011Jun 3, 2014Advanced Cardiovascular Systems, Inc.Rotatable support elements for stents
US8747878Apr 28, 2006Jun 10, 2014Advanced Cardiovascular Systems, Inc.Method of fabricating an implantable medical device by controlling crystalline structure
US8747879May 31, 2006Jun 10, 2014Advanced Cardiovascular Systems, Inc.Method of fabricating an implantable medical device to reduce chance of late inflammatory response
US8752267Aug 9, 2013Jun 17, 2014Abbott Cardiovascular Systems Inc.Method of making stents with radiopaque markers
US8752268Aug 9, 2013Jun 17, 2014Abbott Cardiovascular Systems Inc.Method of making stents with radiopaque markers
US8778256Sep 30, 2004Jul 15, 2014Advanced Cardiovascular Systems, Inc.Deformation of a polymer tube in the fabrication of a medical article
US20090306725 *Nov 16, 2007Dec 10, 2009Sachiko HiromotoMagnesium-based medical device and manufacturing method thereof
US20110313527 *Aug 11, 2009Dec 22, 2011Aap Biomaterials GmbhImplant made of a magnesium alloy and method for the production thereof
DE10128100A1 *Jun 11, 2001Dec 19, 2002Hannover Med HochschuleMedical implant used for humans and animals is made from magnesium alloy containing additions of rare earth metals and lithium
DE10163106A1 *Dec 24, 2001Jul 10, 2003Univ HannoverMedizinische Implantate, Prothesen, Protheseteile, medizinische Instrumente, Geräte und Hilfsmittel aus einem halogenid-modifizierten Magnesiumwerkstoff
DE10253634A1 *Nov 13, 2002May 27, 2004Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro BerlinEndoprothese
DE10361941A1 *Dec 24, 2003Jul 28, 2005Restate Patent AgCoating for the outer surface of a medical implant, especially a stent or electrode, comprises magnesium, a magnesium alloy or a magnesium salt
DE102004026104A1 *May 25, 2004Dec 15, 2005Restate Patent AgImplantat zur Gefäßligatur
DE102004043231A1 *Sep 7, 2004Mar 9, 2006Biotronik Vi Patent AgEndoprothese aus einer Magnesiumlegierung
DE102004043232A1 *Sep 7, 2004Mar 9, 2006Biotronik Vi Patent AgEndoprothese aus einer Magnesiumlegierung
DE102005003188A1 *Jan 20, 2005Jul 27, 2006Restate Patent AgMedizinisches Implantat aus einer amorphen oder nanokristallinen Legierung
DE102010019365A1May 5, 2010Jun 22, 2011Acoredis GmbH, 07743Bioabsorbable occlusion device, which is introduced by a catheter in a folded condition in a patient's body, where the device in an area of its surrounding envelope comes to a constriction, useful to treat e.g. atrial septal defects
EP0966979A2 *Jun 11, 1999Dec 29, 1999BIOTRONIK Mess- und Therapiegeräte GmbH & Co Ingenieurbüro BerlinImplantable bioresorbable support for the vascular walls, in particular coronary stent
EP1270023A2 *Jul 17, 1998Jan 2, 2003Meyer, JörgMetallic implant which is degradable in vivo
EP1419793A1 *Oct 17, 2003May 19, 2004Biotronik GmbH & Co. KGEndoprosthesis with a supporting structure of magnesium alloy
EP1552856A1Jul 17, 1998Jul 13, 2005Meyer, JörgMetallic implant which is degradable in vivo
EP1618901A1 *Jun 22, 2005Jan 25, 2006Biotronik VI Patent AGBiokompatible and biodegradable suture and staple material for surgical use
EP1959025A1 *Nov 16, 2006Aug 20, 2008National Institute for Materials ScienceMagnesium-based biodegradable metal material
WO1999003515A2 *Jul 17, 1998Jan 28, 1999Meyer JoergMetallic implant which is degradable in vivo
WO2006008104A1 *Jul 16, 2005Jan 26, 2006Ossacur AgImplantable body for spinal fusion
WO2010034098A1Feb 18, 2009Apr 1, 2010Integran Technologies, Inc.In-vivo biodegradable medical implant
Classifications
U.S. Classification606/76, 420/410
International ClassificationC22C25/00, A61B17/58, C22C23/06, C22C23/00, C22C24/00, A61L31/02, A61B17/00, A61L31/14, A61F2/00
Cooperative ClassificationA61F2310/00041, A61B2017/00004, C22C24/00, C22C23/06, A61L31/022, A61L2430/02, C22C23/00, C22C25/00, A61B17/58, A61L31/148
European ClassificationC22C25/00, C22C24/00, C22C23/00, A61B17/58, C22C23/06, A61L31/14K, A61L31/02B